Original Articles
Copyright ©The Author(s) 2000.
World J Gastroenterol. Apr 15, 2000; 6(2): 216-219
Published online Apr 15, 2000. doi: 10.3748/wjg.v6.i2.216
Table 1 Inhibitory effects of CAO on growth of hepatoma in mice
ExperimentDrugsDose (kg¯¹·d¯¹)NumberBody weight change (g)Tumor weight (g)Tumor inhibitory rate (%)
1Ns0.2 mL76.901.08 ± 0.22
5-FU40 mg7-2.000.35 ± 0.1367.6b
CAO100 mg74.350.52 ± 0.1651.8b
2Ns0.2 mL105.551.72 ± 0.45
5-FU20 mg10-1.850.45 ± 0.1573.8b
CAO100 mg104.600.84 ± 0.3151.2b
Table 2 Effects of CAO on the hepatoma DNA parameters detected with ICM in mice
GroupDONA (μm2)DI5CER (%)2C (%)3-5C (%)
Negative control430 ± 1601073 ± 1014.48 ± 0.7170.9 ± 14.92.97 ± 5.6928.2 ± 16.0
CAO249 ± 70b623 ± 228a2.38 ± 0.67b30.0 ± 15.1b29.00 ± 9.34b41.0 ± 17.4
Table 3 Effects of CAO on the expressions of hepatoma PCNA in mice
GroupPCNA-LI (%)
Negative control40.0 ± 5.7
Positive control25.1 ± 3.6 b
CAO29.9 ± 3.9 b